Related Experiment Video

Updated: Jan 20, 2026

FISH for Pre-implantation Genetic Diagnosis
07:34

FISH for Pre-implantation Genetic Diagnosis

Published on: February 23, 2011

37.8K

Pathophysiology, Diagnosis, and Management of the No-Reflow Phenomenon

Joseph Allencherril1, Hani Jneid2, Dan Atar3

  • 1Section of Cardiology, Department of Medicine, Baylor College of Medicine, One Baylor Plaza, Houston, TX, 77030, USA. jallencherril@gmail.com.

Cardiovascular Drugs and Therapy
|August 17, 2019
PubMed

Insights

The no-reflow phenomenon, where blood flow isn't restored after heart attack treatment, is common and linked to worse outcomes. Understanding no-reflow is crucial for improving survival rates in ST-elevation myocardial infarction (STEMI) patients.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Clinical Medicine

Background:

  • Successful reperfusion therapy for ST-elevation myocardial infarction (STEMI) does not guarantee myocardial tissue perfusion.
  • The "no-reflow" phenomenon is a prevalent complication following reperfusion in STEMI.
  • No-reflow is associated with adverse cardiovascular outcomes and may explain stagnant in-hospital mortality rates.

Purpose of the Study:

  • To discuss the pathophysiology of the no-reflow phenomenon in STEMI.
  • To highlight clinical diagnosis and management strategies for no-reflow.
  • To identify limitations in current no-reflow assessment and management.

Main Methods:

  • Review of existing literature on no-reflow pathophysiology.
  • Discussion of diagnostic criteria and clinical assessment methods.
  • Analysis of current therapeutic approaches and their limitations.

Main Results:

  • No-reflow pathophysiology involves complex microvascular dysfunction.
  • Clinical diagnosis relies on imaging and hemodynamic assessments, with limitations.
  • Current management strategies are often empirical and lack targeted efficacy.

Conclusions:

  • Understanding the dynamic nature of no-reflow is essential for improving STEMI patient outcomes.
  • No-reflow represents a significant barrier to further reductions in STEMI mortality.
  • Targeting the no-reflow phenomenon offers a promising avenue for future research and clinical intervention.

Keywords:
Cardiovascular diseaseIschemic heart diseaseMicrovascular diseaseMyocardial infarction

More Related Videos

Strategies for Tracking Anastasis, A Cell Survival Phenomenon that Reverses Apoptosis12:55

Strategies for Tracking Anastasis, A Cell Survival Phenomenon that Reverses Apoptosis

Published on: February 16, 2015

18.6K
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

8.0K

Related Concept Videos

Tip-of-the-Tongue Phenomenon01:10

Tip-of-the-Tongue Phenomenon

The tip-of-the-tongue (TOT) phenomenon is a cognitive experience characterized by a temporary inability to retrieve specific information from memory despite having a strong feeling of knowing the information. Although individuals cannot access the target word or detail, they frequently recall related elements, such as its initial letter, syllable count, or context. This partial retrieval often causes frustration, as one might recognize a familiar face or know that a name starts with a specific...
499
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.2K
Pathophysiology of Vomiting01:22

Pathophysiology of Vomiting

Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through...
2.8K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
2.7K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
824
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.2K